Joey A. Muns

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice

Katerina T. Xenaki, Bram Dorresteijn, Joey A. Muns et al. · Theranostics · 2021 · 81 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Novel Platinum(II)–Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F–Conjugated Trastuzumab

Niels J. Sijbrandi, Eugen Merkul, Joey A. Muns et al. · Cancer Research · 2016 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody–Drug Conjugates: Taking Advantage of Dual Labeling with ^195mPt and ⁸⁹Zr

Joey A. Muns, Verónica Montserrat, Hendrik-Jan Houthoff et al. · Journal of Nuclear Medicine · 2018 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Platinum(II) as Bifunctional Linker in Antibody–Drug Conjugate Formation: Coupling of a 4‐Nitrobenzo‐2‐oxa‐1,3‐diazole Fluorophore to Trastuzumab as a Model

Dennis C. J. Waalboer, Joey A. Muns, Niels J. Sijbrandi et al. · ChemMedChem · 2015 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

On the Reactivity and Selectivity of Galacturonic Acid Lactones

Alphert E. Christina, Joey A. Muns, Jeremy Q. A. Olivier et al. · European Journal of Organic Chemistry · 2012 · 21 citations

Pharmacy, Biochemistry, Carbohydrate Chemistry +15